Bharat Immunologicals & Biologicals share news and announcements
BSE: 524663Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹9.18.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- Share count not known3,103rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Share count not known
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Share count not known
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- –
- Volume, BSEVolume. Shares traded on the last trading day.
- 28,767
Bharat Immunologicals & Biologicals share news and announcements
263 announcements, routine notices left out, newest first. Page 2 of 6.
Nov 2021
Oct 2021
22 Oct · Board meeting
Meeting on 29 Oct 2021: quarterly results19 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....11 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Aug 2021
Jul 2021
19 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....15 Jul · Board meeting
Meeting on 27 Jul 202113 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2021
30 Jun · Submission Of Reviewed Annual Accounts For The Financial Year 2020-21 In Compliance Of Regulation 33 Of SEBI LODR Please.
May 2021
27 May · Certificate From Practicing Company Secretary Under Regulation 40 Of SEBI (LODR) Regulations 2015 For The Half Year Ended On 31.03.2021
Apr 2021
18 Apr · Submission Of Information Under Regulation 30 Of SEBI LODR
12 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....8 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2021
3 Feb · Board meeting
Meeting on 10 Feb 2021: quarterly results
Jan 2021
11 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....11 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 05 Jan · LIMITED REVIEW REPORT ON UAFR SEPTEMBER 2020
Dec 2020
31 Dec · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....22 Dec · Board meeting
Meeting on 30 Dec 2020: annual general meeting and quarterly results
Nov 2020
5 Nov · Certificate From Practicing Company Secretary Under Regulation 40 Of SEBI (LODR) Regulations 2015 For The Half Year Ended On 30.09.2020
Oct 2020
20 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....15 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2020
4 Sep · Board meeting
Meeting on 11 Sep 2020: quarterly results
Jul 2020
31 Jul · Submission Of Audited Balance Sheet And Statement Of Profit And Loss Account For The Year Ended 31.03.2020 As Per SEBI (LODR) - Reg.
20 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....10 Jul · Board meeting
Meeting on 20 Jul 2020: audited results and quarterly results6 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2020
29 May · Certificate From Practicing Company Secretary Under Regulation 40 Of SEBI (LODR) Regulations 2015 For The Half Year Ended On 31.03.2020
19 May · Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ending On 31.03.2020
Apr 2020
29 Apr · Legal
Exchange had sought clarification from Bharat Immunologicals & Biologicals Corporation Ltd with respect to "interview of CEO of the Company on NDTV 24×7 news channel, wherein he had ....